Summary:
Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at Reliance Pathology Partners LLC on 03/30/22 . The laboratory is not in compliance with 42 CFR Part 493, Requirements for Laboratories. The following is a description of the standard level deficiencies. D5805 TEST REPORT CFR(s): 493.1291(c) The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: Based on record review and phone interview with the Human Resource Manager, the laboratory failed to have the correct name of the laboratory where the professional component (slide interpretation) for histopathology testing was performed on 3 out of 3 (#1, #2, #3) patient histopathology reports reviewed. Findings Included: Review of final histopathology reports for Patient #1 dated 4/22/21, Patient #2 dated 5/25/21, and Patient #3 12/08/21 revealed the wrong laboratory name where the professional component (slide interpretation) was performed. On 03/30/22 at 12:40 PM, the Human Resource Manager stated that she had not caught the mistake at this office. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --